| Trade mark | ||
|---|---|---|
| (210) | Application number | 2006 1448 |
| (220) | Date of filing the application | 2006-07-28 |
| (111) | Registration number | 56152 |
| (151) | Registration date | 2007-12-12 |
| (181) | Expire | 2026-07-28 |
| (450) | Date of registration publication, bulletin No. | 2008-01-25, 2008/1 |
| Legal status |
Registered
Seniority claimed for EUTM
|
|
| Seniority |
018768418 |
|
| Reproduction of the mark | ||
| (540) | RELISTOR | |
| (531) | Indication of Vienna Classification | |
| Indication concerning colors claimed | ||
| (591) | ||
| Indication of International Classification of Goods and Services, list of goods and (or) services | ||
| (511) |
5 farmaciniai preparatai, būtent vaistai, opioidų pašalinio poveikio slopinimui ir pašalinimui. |
|
| Applicant (731) / Owner (732) | ||
| (732) | Name | SALIX PHARMACEUTICALS, INC |
| Address | 8510 Colonnade Center Drive, Raleigh, North Carolina 27615 | |
| Country | US | |
| Attorney or representative | ||
| (740) | Name | Reda Žabolienė |
| Address | METIDA, Verslo centras „VERTAS“, Gynėjų g. 16, LT-01109 Vilnius | |
| Country | LT | |
| Disclaimer | ||
| (526) | ||
| Exhibition priority | ||
| (230) | Date, country | |
| Convention priority | ||
| (300) | Convention priority | |
| Date | ||
| Country | ||